Latest / PETRI DISH PERSPECTIVES
Episode 47: SUN Pharma
Send us Fan Mail
From a small operation built on just ₹10,000 to a global pharmaceutical powerhouse, Sun Pharmaceutical Industries is one of the most compelling growth stories in modern biotech.
In this episode of Petri Dish Perspectives: Biotech Unleashed, we break down how Dilip Shanghvi transformed a niche generics business into one of the largest pharmaceutical companies in the world. We explore Sun Pharma’s early focus on underserved therapeutic areas, its aggressive strategy of acquiring distressed assets, and the pivotal deals that expanded its global footprint, from U.S. market entry…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.